A phase II trial of regorafenib for advanced urothelial cancer (aUC) following prior chemotherapy

被引:1
|
作者
Naik, Gurudatta
Vaishampayan, Ulka N.
Nabell, Lisle
De Shazo, Mollie R.
Nandagopal, Lakshminarayanan
Grivas, Petros
Morgan, Charity
Hardwick, Pamela
Sonpavde, Guru
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Wayne State Univ, Detroit, MI USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
498
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma
    Redman, BG
    Smith, DC
    Flaherty, L
    Du, W
    Hussain, M
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1844 - 1848
  • [22] Sorafenib plus chemotherapy versus chemotherapy alone in advanced pancreatic cancer: A randomized phase II trial
    Cascinu, S.
    Berardi, R.
    Sobrero, A. F.
    Labianca, R.
    Bidoli, P.
    Siena, S.
    Ferraris, D.
    Barni, S.
    Cengarle, R.
    Monteforte, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer
    Artz, A
    Stadler, WM
    Vogelzang, NJ
    Zimmerman, T
    Ryan, C
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (02): : 109 - 113
  • [24] Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy
    Michael, M
    Bishop, JF
    Levi, JA
    Bell, DR
    Zalcberg, JR
    Friedlander, ML
    Olver, IN
    Smith, JG
    Toner, GC
    MEDICAL JOURNAL OF AUSTRALIA, 1997, 166 (10) : 520 - 523
  • [25] Phase 3 KEYNOTE-361 trial: Pembrolizumab (pembro) with or without chemotherapy versus chemotherapy alone in advanced urothelial cancer
    Powles, Thomas
    Gschwend, Juergen E.
    Loriot, Yohann
    Bellmunt, Joaquim
    Geczi, Lajos
    Vulsteke, Christof
    Abdelsalam, Mahmoud
    Gafanov, Rustem
    Bae, Woo Kyun
    Revesz, Janos
    Yamamoto, Yoshiaki
    Anido, Urbano
    Su, Wen-Pin
    Fleming, Mark T.
    Markus, Maurice
    Feng, Dai
    Poehlein, Christian Heinrich
    Alva, Ajjai
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] Phase 2 trial of CV301 vaccine plus atezolizumab (Atezo) in advanced urothelial carcinoma (aUC).
    Sonpavde, Guru P.
    Maughan, Benjamin L.
    McGregor, Bradley Alexander
    Wei, Xiao X.
    Kilbridge, Kerry L.
    Lee, Richard J.
    Yu, Evan Y.
    Schweizer, Michael Thomas
    Montgomery, Robert B.
    Cheng, Heather H.
    Hsieh, Andrew Caleb
    Jain, Rohit K.
    Grewal, Jaspreet Singh
    Pico, Cesar
    Gafoor, Zarina
    Perschy, Teresa Pico
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [27] PHASE-II STUDY OF ESORUBICIN IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA AND NO PRIOR CHEMOTHERAPY - AN ILLINOIS-CANCER-COUNCIL TRIAL
    LOCKER, GY
    HOELTGEN, T
    KILTON, L
    KRAUSS, S
    MCNAMARA, M
    BLOUGH, R
    JOHNSON, C
    CANCER TREATMENT REPORTS, 1987, 71 (7-8): : 765 - 766
  • [28] Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: A phase II trial of the Minnie Pearl Cancer Research Network
    Meluch, AA
    Greco, FA
    Burris, HA
    O'Rourke, T
    Ortega, G
    Steis, RG
    Morrissey, LH
    Johnson, V
    Hainsworth, JD
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (12) : 3018 - 3024
  • [29] Eribulin in advanced urothelial cancer (AUC) patients (pts): A California Cancer Consortium trial-NCI/CTEP 7435
    Quinn, David I.
    Ruel, Nora
    Twardowski, Przemyslaw
    Groshen, Susan G.
    Dorff, Tanya B.
    Pal, Sumanta Kumar
    Stadler, Walter Michael
    Aparicio, Ana
    Lara, Primo
    Newman, Edward M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Phase II trial of irinotecan and raltitrexed in chemotherapy-naive advanced colorectal cancer
    Chiara, S
    Nobile, MT
    Tomasello, L
    Acquati, M
    Taveggia, P
    Murolo, C
    Percivale, P
    Rosso, R
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1391 - 1396